about
[Indications and results for protontherapy in cancer treatments].Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer.Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experienceAdjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.Visual complaints in intracranial germinomas.Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults.Intracranial ependymomas in children: society of pediatric oncology experience with postoperative hyperfractionated local radiotherapy.Radiation therapy in pediatric pineal tumors.Paediatric brain tumours: A review of radiotherapy, state of the art and challenges for the future regarding protontherapy and carbontherapy.A review of uncertainties in radiotherapy dose reconstruction and their impacts on dose-response relationships.Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity.Paediatric radiation oncology in the care of childhood cancer: A position paper by the International Paediatric Radiation Oncology Society (PROS).Cerebrovascular Diseases in Childhood Cancer Survivors: Role of the Radiation Dose to Willis Circle Arteries.Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991.Nonoperative management of squamous-cell carcinoma of the rectum.Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study.High-Dose Hypofractionated Radiation Therapy for Noncompressive Vertebral Metastases in Combination With Zoledronate: A Phase 1 Study.Salvage radiotherapy with or without hormone therapy: for whom and when?Delineation of the Prostate Bed: The "Invisible Target" Is Still an Issue?Prostate cancer and hypofractionation: really a new standard of care?Phase I study of daily irinotecan as a radiation sensitizer for locally advanced pancreatic cancer.Role of brachytherapy in the treatment of cancers of the anal canal. Long-term follow-up and multivariate analysis of a large monocentric retrospective series.Fertility and pregnancy outcome after abdominal irradiation that included or excluded the pelvis in childhood tumor survivors.Could concomitant radio-chemotherapy improve the outcomes of early-stage node negative anal canal cancer patients? A retrospective analysis of 122 patients.Inverted papilloma with associated carcinoma of the nasal cavity and paranasal sinuses: treatment outcomes.Second cancer after total-body irradiation (TBI) in childhood.MB-47RISK OF HIPPOCAMPAL REGION METASTASIS IN HIGH RISK MEDULLOBLASTOMA: SUFFICIENT RATIONAL FOR HIPPOCAMPAL SPARING DURING CRANIOSPINAL IRRADIATION?A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-oImpact of 18F-fluoro-2-deoxyglucose positron emission tomography on treatment strategy and radiotherapy planning for stage I-II Hodgkin disease: a prospective multicenter study.Pre-radiation chemotherapy improves survival in pediatric diffuse intrinsic pontine gliomas.Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98.Development and validation of a machine learning-based predictive model to improve the prediction of inguinal status of anal cancer patients: A preliminary report.Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial.[Use of hypnosis in radiotherapy as an alternative to general anesthesia in pediatric radiation oncology].Hippocampal Sparing During Craniospinal Irradiation: What Did We Learn About the Incidence of Perihippocampus Metastases?[French organization of paediatric radiation treatment: Results of a survey conducted by the radiotherapy Committee of the French Society of Paediatric Cancers (SFCE)].Plasma ceramide, a real-time predictive marker of pulmonary and hepatic metastases response to stereotactic body radiation therapy combined with irinotecan.Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01.Active breathing control for Hodgkin's disease in childhood and adolescence: feasibility, advantages, and limits.Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.
P50
Q33276198-4809A8AE-967D-4991-B63D-7A2D29841E06Q33848566-B1D04919-4799-4D34-9D1D-60B8CFA8E3ECQ34480683-E8A370D5-AF60-411B-882D-6AB6F6AEB7BEQ34679120-D5C28611-D79F-402C-97C2-04777614BDBAQ36354876-7811A8D8-AAFC-4B2A-B075-C4E0090601D3Q36820329-7BA70A15-18C9-45A7-9E3E-94FEE42F6DC4Q37442178-2E7A4899-61AD-48AD-863B-BEEC80FA22A1Q38328855-05E85214-31D3-40C7-9E54-38AD802BDCE6Q38628093-53B22D71-FF7C-4A31-AF3C-028E4ED4CBECQ38766375-B4C218B9-B529-4403-A372-F7D5EF3DDF03Q38794946-F06B93DD-0CB5-423B-8506-58C4679B4F33Q38815410-40C79D8C-599E-4084-B737-98B59841497BQ39031673-618320CE-F9D4-4EA3-AA3B-B2114D130D9FQ39920955-D27C7F97-6B0C-465F-8385-A176D83386FFQ40242325-965CECCF-CECA-46B0-93DC-B8E8A72D8081Q40508582-E80F547A-7B85-41C3-B5E5-689FD91DB8CEQ40509415-F5C3D595-CFA8-4246-BD10-19C014D4C100Q42085518-D441F629-88D6-4058-BF07-33700C11F6C7Q42236979-0510030F-F9E6-4E6E-A8A1-6409C9961F12Q42343420-93BE4614-A63E-4F86-BADD-52D03FC119EEQ43179813-9A144816-A6D2-4250-A35E-AC8D8D074806Q43409549-8D42A203-4B84-4EEA-B232-0F272A6FF12EQ44131142-AF63F2B8-AD15-49B3-870F-7B744C1E0C3AQ44713931-B7B4C40E-B95A-4445-8D50-540DD5AC85F8Q44732267-4670C3DD-3AD5-4D2D-83CA-0FA32CC0625CQ44824430-6747EB7D-CC91-4DD4-9AAB-9CC81F4F4659Q46354801-7DC5A636-45D8-4595-AFE6-352D8BA25997Q46417062-567661C2-9BF8-4A23-AC7D-EFD0E9AAED4BQ46566439-D4AD6707-7272-41F4-AE3C-10B36C9C6171Q48638748-774691F9-B9BB-4E1C-ADB6-C81E66873BCCQ48711022-1C73C10E-EBD6-4BE4-ACDA-4DBDEE68AE94Q49417105-78571905-E6C2-4F78-A0D5-72FA34A620AFQ50429593-713EBD88-BEC4-4373-BF63-AF07FAC9830BQ51065909-199709D7-302F-43B9-8C5C-A44DAF80B0E2Q52683611-5D32A8AB-71F3-49FB-8B65-4B73E93F4878Q53060815-D471ED65-EB48-428F-B688-EEF7AF197185Q53115003-56DB90BA-524F-4F44-A221-4B80E53A3EE7Q53224792-0AA0A3D0-ADF8-4910-BF76-3CD5FA900E52Q53505229-72921328-8FB9-49F8-A625-41E8B9E869C5Q54218117-8BB92124-04B3-4AF2-811D-A8EA6E598998
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Christian Carrie
@ast
Christian Carrie
@en
Christian Carrie
@es
Christian Carrie
@nl
Christian Carrie
@sl
type
label
Christian Carrie
@ast
Christian Carrie
@en
Christian Carrie
@es
Christian Carrie
@nl
Christian Carrie
@sl
prefLabel
Christian Carrie
@ast
Christian Carrie
@en
Christian Carrie
@es
Christian Carrie
@nl
Christian Carrie
@sl
P1053
K-5488-2014
P106
P21
P31
P3829
P496
0000-0002-0766-2547